--- title: "HIMS 的多頭投資者應該關注這一歷史圖表信號" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/298955828.md" description: "Hims & Hers Health (HIMS) 股票面臨歷史性的看跌信號，其 50 天的認沽/認購比率超過過去一年讀數的 98%。歷史數據顯示，在出現此類信號後，股價下跌的概率為 100%，平均損失為 15%。儘管當前分析師共識傾向於買入，目標價為 31.53 美元，但期權市場指標顯示出低波動性預期和進一步下行的潛力" datetime: "2026-09-14T19:26:44.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/298955828.md) - [en](https://longbridge.com/en/news/298955828.md) - [zh-HK](https://longbridge.com/zh-HK/news/298955828.md) generator: "portal-rs" --- # HIMS 的多頭投資者應該關注這一歷史圖表信號 Drugmaker **Hims & Hers Health Inc (NYSE:HIMS)** stock is moving 6.6% higher to trade at $29.34 this afternoon. Despite its two-day pop, the shares have fumbled longer term, struggling to recover from a drawdown from its early July highs. Now off 3% in 2026, another pullback could be looming, with the 260-day moving average overhead and a historically bearish signal now flashing. HIMS sports a 50-day call/put volume ratio of 4.53 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which stands higher than 98% of readings from the past year. There have been three instances in the last three years that the equity's 50-day buy-to-open put/call ratio crossed over 1.0 and moved into the 90th percentile. Per Schaeffer's Senior Quantitative Analyst Rocky White, **the drugmaker** was lower one month later 100% of the time after these signals, averaging a 15% loss. From its current perch, a move of similar magnitude would place the stock just above $25. Echoing this, Hims & Hers Health stock sports a Schaeffer's put/call open interest ratio (SOIR) of 0.61. This ratio ranks higher than just 29% of readings from the past year, suggesting short-term bears have plenty of room to move in. There is ample opportunity for downgrade and price-target cuts, too. Heading into today, 36 of the 44 covering brokerages sport a "buy" or "strong buy" recommendation. Plus, the average 12 months price target of $31.53 comes in at a 7.5% premium to current levels. Options are looking affordable as well, per the stock's Schaeffer's Volatility Index (SVI) of 39%, which stands higher than just 9% of all other readings from the past year. In other words, near-term option traders are pricing in relatively low volatility expectations at the moment. ### 相關股票 - [HIMS.US](https://longbridge.com/zh-HK/quote/HIMS.US.md) - [HIMZ.US](https://longbridge.com/zh-HK/quote/HIMZ.US.md) - [HIMY.US](https://longbridge.com/zh-HK/quote/HIMY.US.md) - [HIYY.US](https://longbridge.com/zh-HK/quote/HIYY.US.md) - [CBOE.US](https://longbridge.com/zh-HK/quote/CBOE.US.md) - [NDAQ.US](https://longbridge.com/zh-HK/quote/NDAQ.US.md) ## 相關資訊與研究 - [財報前瞻 | Hims & Hers 周一盤後放榜，毛利率能否止跌成主線](https://longbridge.com/zh-HK/news/304834193.md) - [期權熱點｜周一 HIMS 大跌 11%，部分看跌期權飆升 183%](https://longbridge.com/zh-HK/news/304953324.md) - [Hims & Hers Health｜8-K：2026 財年 Q3 營收 8.9 億美元](https://longbridge.com/zh-HK/news/304912593.md) - [Hims 股票成焦點：財報發佈前福利計劃擴容](https://longbridge.com/zh-HK/news/304700590.md) - [HIMS：營收激增，但利潤率壓縮及法律費用導致第三季度淨虧損](https://longbridge.com/zh-HK/news/304909727.md) --- > **免責聲明: 本文僅供參考，不構成任何投資建議。**